Nanoparticles in Drug Delivery: Potential Green Nanobiomedicine Applications

REFERENCES

• Nielloud , F. and Marti-Mestres , G. 2008 . Drugs and the Pharmaceutical Sciences, , 2nd ed. , New York : Informa Healthcare .
   Google Scholar
• Gao , L. , Zhang , D. and Chen , M. 2008 . Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system . J. Nanoparticle Res. , 10 : 845 – 862 .
   Google Scholar
• Ravichandran , R. 2009 . Nanotechnology based drug delivery systems . NanoBiotechnology , http://www.springerlink.com/content/j6440717w6232125in press. DOI: 10.1007/s12030-009-9028-2
   Google Scholar
• Liu , R. 2008 . Water-Insoluble Drug Formulation: Pharmaceutical Emulsions and Suspensions, , 2nd ed. , Baco Raton , FL : CRC Press .
   Google Scholar
• Rasenack , N. , Steckel , H. and Muller , B. W. 2003 . Micronization of anti-inflammatory drugs for pulmonary delivery by a controlled crystallization process . J. Pharm. Sci. , 92 : 35 – 44 .
   Google Scholar
• Steckel , H. , Rasenack , N. and Muller , B. W. 2003 . In-situ-micronization of disodium cromoglycate for pulmonary delivery . Eur. J. Pharm. Biopharm. , 55 : 173 – 180 .
   Google Scholar
• Steckel , H. 2003 . In vitro characterization of jet-milled and in-situmicronizedfluticasone-17-propionate . Int. J. Pharm. , 258 : 65 – 75 .
   Google Scholar
• Rasenack , N. and Muller , B. W. 2004 . Micron-size drug particles: common and novel micronization techniques . Pharm. Dev. Technol. , 9 : 1 – 13 .
   Google Scholar
• Liversidge , G. G. Surface modified drugs nanoparticles . US Patent 5,145,684 . 1992 . Sterling Drug, New York; USA
   Google Scholar
• Muller , R. H. Pharmaceutical nanosuspensions for medical administration as systems with increased saturation solubility and rate of solution . US Patent 5,858,410 . 1999 . USA
   Google Scholar
• Ostrander , K. D. , Bosch , H. W. and Bondanza , D. M. 1999 . An in-vitro assessment of a NanoCrystal beclomethasone dipropionate colloidal dispersion via ultrasonic nebulization . Eur. J. Pharm. Biopharm. , 48 : 207 – 215 .
   Google Scholar
• Sri , K. V. 2007 . Preparation and characterization of quercetin and rutin cyclodextrin inclusion complexes . Drug Dev. Ind. Pharm. , 33 : 245 – 253 .
   Google Scholar
• Calabro , M. L. 2005 . The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays . J. Pharm. Biomed. Anal. , 36 : 1019 – 1027 .
   Google Scholar
• Brewster , M. E. and Loftsson , T. 2007 . Cyclodextrins as pharmaceutical solubilizers . Adv. Drug Deliv. Rev. , 59 : 645 – 666 .
   Google Scholar
• Loftsson , T. 2005 . Cyclodextrins in drug delivery . Expert Opin. Drug Deliv. , 2 : 335 – 351 .
   Google Scholar
• Loftsson , T. and Brewster , M. E. 1996 . Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization . J. Pharm. Sci. , 85 : 1017 – 1025 .
   Google Scholar
• Loftsson , T. , Brewster , M. E. and Másson , M. 2004 . Role of cyclodextrins in improving oral drug delivery . Am. J. Drug. Deliv. , 2 : 1 – 15 .
   Google Scholar
• Mu , X. and Zhong , Z. 2006 . Preparation and properties of poly(vinyl alcohol)-stabilized liposomes . Int. J. Pharm. , 318 : 55 – 61 .
   Google Scholar
• Johnston , M. J. 2007 . Characterization of the drug retention and pharmacokinetic properties of liposomal nanoparticles containing dihydrosphingomyelin . Biochim. Biophys. Acta , 1768 : 1121 – 1127 .
   Google Scholar
• Kreuter , A. 2005 . Liposomal pegylated doxorubicin versus low-dose recombinant interferon Alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers . Cancer Invest. , 23 : 653 – 659 .
   Google Scholar
• Dannenfelser , R. M. 2004 . Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycolpolysorbate 80 solid dispersion carrier system . J. Pharm. Sci. , 93 : 1165 – 1175 .
   Google Scholar
• Joshi , H. N. 2004 . Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture . Int. J. Pharm. , 269 : 251 – 258 .
   Google Scholar
• Karavas , E. 2007 . Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions . Eur. J. Pharm. Biopharm. , 66 : 334 – 347 .
   Google Scholar
• Overhoff , K. A. 2007 . Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing . Int. J. Pharm. , 336 : 122 – 132 .
   Google Scholar
• Serajuddin , A. T. 1999 . Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs . J. Pharm. Sci. , 88 : 1058 – 1066 .
   Google Scholar
• Torchilin , V. P. 2008 . Nanotechnology in Drugs, , 2nd ed. , London : Imperial College Press .
   Google Scholar
• Sahoo , S. K. and Labhasetwar , V. 2008 . Nanotech approaches to drug delivery and imaging . Drug Discov. Today , 8 : 1112 – 1120 .
   Google Scholar
• Salata , O. V. 2004 . Applications of nanoparticles in biology and medicine . J Nanobiotechnol. , 2 : 1 – 6 .
   Google Scholar
• Suri , S. S. , Fenniri , H. and Singh , B. 2007 . Nanotechnology-based drug delivery systems . J Occup. Med. Toxicol. , 1 : 2 – 16 .
   Google Scholar
• Kirupakar , B. R. 2009 . Nanosuspension drug delivery: Technology and application . Express Pharma Pulse , : 1 – 6 . http://www.expresspharmaonline.com./20050224/nanotechol.shtml
   Google Scholar
• Chingunpituk , J. 2007 . Nanosuspension technology for drug delivery. Walailak . J. Sci, Tech. , 4 : 139 – 153 .
   Google Scholar
• US Pharmacopoeia Conventional . 2000 . The United States Pharmacopoeia, , 24th rev. ed , 8 Rockville , MD : Rockville: The United States Pharmacopoeia Conventional Inc. .
   Google Scholar
• Remington , J. P. 1980 . Remington's Pharmaceutical Sciences, , 16th ed. , 176 – 178 . Easton , PA : Mack .
   Google Scholar
• Mosharraf , M. , Sebhatu , T. and Nystrom , C. 1999 . The effects of disordered structure on the solubility and dissolution rates of some hydrophilic, sparingly soluble drugs . Int. J. Pharm. , 177 : 29 – 51 .
   Google Scholar
• Mosharraf , M. and Nystrom , C. 1999 . The effect of dry mixing on the apparent solubility of hydrophobic, sparingly soluble drugs . Eur. J. Pharm. Sci. , 9 : 145 – 156 .
   Google Scholar
• Martin , A. , Swarbrick , J. and Cammarata , A. 1993 . Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences, , 4th subed. , 125 – 142 . 212 – 250 . 329 – 334 . Philadelphia : Lippincott Williams & Wilkins . Philadelphia
   Google Scholar
• Myrdal , P. B. and Yalkowsky , S. H. 2002 . Solubilization of Drugs in Aqueous Media, 2nd ed., Encyclopedia of Pharmaceutical Technology , Edited by: Swarbick , J. and Boylan , J. C. Vol. 3 , 2458 – 2580 . New York : Marcel Dekker .
   Google Scholar
• Wells , J. I. 1988 . Pharmaceutical Preformulation: The Physicochemical Properties of Drug Substances, , 1st ed. , 21 – 85 . 94 – 100 . Chichester : Ellis Horwood . Chichester
   Google Scholar
• Florence , A. T. and Attwood , D. 1981 . Physicochemical Principles of Pharmacy, , 2nd ed. , 89 – 90 . 131 – 172 . 199 – 208 . London : Macmillan Publishers .
   Google Scholar
• Sekiguchi , K. and Obi , N. 1961 . Studies on absorption of eutectic mixture. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man . Chem. Pharm. Bull. , 9 : 866 – 872 .
   Google Scholar
• Goldberg , A. H. , Gibaldi , M. and Kanig , J. L. 1966 . Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures II. Experimental evaluation of eutectic mixture: urea acetaminophen system . J. Pharm. Sci. , 55 : 482 – 487 .
   Google Scholar
• Hildebrand , J. H. and Scott , R. L. 1950 . Solubility of Nonelectrolytes, , 3rd ed. , 11 – 13 . 47 160 175 – 197 . New York : Reinhold .
   Google Scholar
• Scatchard , G. 1931 . Equilibria in non-electrolyte solutions in relation to the vapor pressure and densities of the components . Chem. Rev. , 8 : 321 – 333 .
   Google Scholar
• Noyes , A. A. and Whitney , W. R. 1897 . The rate of solution of solid substances in their own solutions . J. Am. Chem. Soc. , 19 : 930 – 934 .
   Google Scholar
• Hixon , A. W. and Crowell , J. H. 1931 . Dependence of reaction velocity upon surface and agitation. I. Theoretical consideration . Ind. Eng. Chem. , 23 : 923 – 931 .
   Google Scholar
• Amidon , G. L. 1995 . A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability . Pharm. Res. , 12 : 413 – 420 .
   Google Scholar
• http://en.wikipedia.org/wiki/Biopharmaceutics_Classification_System
   Google Scholar
• Hite , M. , Turner , S. and Cathy Federici , R. C. 2002 . Part 1: Oral Delivery of Poorly Soluble Drugs , 1 – 3 . Bothwell , WA : Research and Product Development Group at SCOLR® Pharma Inc. .
   Google Scholar
• Hecq , J. 2005 . Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine . Int. J. Pharm. , 299 : 167 – 177 .
   Google Scholar
• Keck , C. M. and Muller , R. H. 2006 . Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation . Eur. J. Pharm. Biopharm. , 62 : 3 – 16 .
   Google Scholar
• Merisko-Liversidge , E. , Liversidge , G. G. and Cooper , E. R. 2003 . Nanosizing: a formulation approach for poorly-water-soluble compounds . Eur. J. Pharm. Sci. , 18 : 113 – 120 .
   Google Scholar
• Muller , R. H. , Böhm , B. H. L. and Grau , M. J. 2000 . “ Nanosuspensions—a formulation approach for poorly soluble and poorly bioavailable drugs ” . In Handbook of Pharmaceutical Controlled Release , Edited by: Wise , D. L. 345 – 357 . New York : Marcel Dekker .
   Google Scholar
• Muller , R. H. , Jacobs , C. and Kayser , O. 2003 . “ DissoCubes—a novel formulation for poorly soluble and poorly bioavailable drugs ” . In Modified-Release Drug Delivery Systems , Edited by: Rathbone , M. J. , Hadgraft , J. and Roberts , M. S. 135 – 149 . New York : Marcel Dekker .
   Google Scholar
• Muller , R. H. and Akkar , A. 2004 . “ Drug nanocrystals of poorly soluble drugs ” . In Encyclopedia of Nanoscience and Nanotechnology; , Edited by: Nalwa , H. S. 627 – 638 . Valencia , CA : American Scientific Publishers .
   Google Scholar
• Muller , R. H. and Keck , C. M. 2007 . “ Improvement of delivery & solubility of poorly soluble drugs by nanonisation ” . In Konferenzdokumentation LTS Academy
   Google Scholar
• Liversidge , G. G. and Conzentino , P. 1995 . Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats . Int. J. Pharm. , 125 ( 2 ) : 309 – 313 .
   Google Scholar
• Muller , R. H. , Jacobs , C. and Kayser , O. 2000 . Nanosuspensions for the Formulation of Poorly Soluble Drugs, Pharmaceutical Emulsions and Suspensions , Edited by: Nielloud , F. and Marti-Mestres , G. 383 – 407 . Marcel Dekker .
   Google Scholar
• Wu , T. H. 2008 . Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles . Int. J. Pharm. , 346 : 160 – 168 .
   Google Scholar
• Auweter , H. Precipitated water-insoluble colorants in colloid disperse form . US Patent 6,494,924 . 2002 . BASF Aktiengesellschaft; USA
   Google Scholar
• List , M. and Sucker , H. Pharmaceutical colloidal hydrosols for injection . GB Patent 2200048 . 1988 . Sandoz Ltd., Switzerland; UK
   Google Scholar
• Sucker , H. and Gassmann , P. Improvements in pharmaceutical compositions . GB Patent 2269536A . 1994 . Sandoz Ltd., Switzerland; UK
   Google Scholar
• Liversidge , G. G. and Cundy , K. C. 1995 . Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs . Int. J.Pharm. , 125 : 91 – 97 .
   Google Scholar
• Muller , R. H. , Mäder , K. and Krause , K. Verfahren zur schonenden Herstellung von hochfeinen Micro-/Nanopartikeln . PCT Application PCT/EP00/06535 . 2000 . Germany
   Google Scholar
• Kipp , J. E. Microprecipitation method for preparing submicron suspensions . US Patent 6,607,784 . 2003 . Baxter International Inc., Deerfield, IL; USA
   Google Scholar
• Petersen , R. D. Nanocrystals for use in topical fomulations and method of production thereof . PCT/EP2007/009943 . 2006 . Abbott GmbH; Germany
   Google Scholar
• Weder , H. G. and Hoogevest , V. Nanosuspensions for intravenous administration . US Patent 5,726,164 . 1998 . USA
   Google Scholar
• Muller , R. H. , Benita , S. and Bohm , B. 1998 . Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs , 396 Stuttgart : Medpharm Scientific Publishers . Stuttgart
   Google Scholar
• Muller , R. H. , Möschwitzer , J. and Bushrab , F. N. 2006 . “ Manufacturing of nanoparticles by milling and homogenisation techniques ” . In Nanoparticle Technology for Drug Delivery , Edited by: Gupta , R. B. and Kompella , U. B. 21 – 52 . New York : Tayler & Francis .
   Google Scholar
• Jinno , J. 2006 . Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs . J Control Release , 111 : 56 – 64 .
   Google Scholar
• Rao , Y. M. , Pavan Kumar , M. and Apte , S. 2008 . Formulation of nanosuspensions of albendazole for oral administration . Curr. Nanosci. , 4 : 53 – 58 .
   Google Scholar
• Buckton , G. and Beezer , A. E. 1992 . The relationship between particle size and solubility . Int. J. Pharm. , 82 : R7 – R10 .
   Google Scholar
• Muller , R. H. , Jacobs , C. and Kayser , O. 2001 . Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future . Adv. Drug Deliv. Rev. , 47 : 3 – 19 .
   Google Scholar
• Mukerjee , P. 1972 . Thermodynamic aspects of solubility of small particles . J. Pharm. Sci. , 61 : 478 – 479 .
   Google Scholar
• Muller , R. H. 1998 . “ Nanosuspensionen—eine neue Formulierung fürschwerlösliche Arzneistoffe ” . In Pharmazeutische Technologie: Moderne Arzneiformen, , 2nd ed. , Edited by: Müller , R. H. and Hildebrand , G. E. 393 – 400 . Stuttgart : Wissenschaftliche Verlagsgesellschaft . Stuttgart
   Google Scholar
• Mosharraf , M. and Nystrom , C. 1995 . The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs . Int. J. Pharm. , 122 : 35 – 47 .
   Google Scholar
• Moschwitzer , J. 2006 . Drug Nanocrystals Prepared by High Pressure Homogenisation—The Universal Formulation Approach for Poorly Soluble Drugs , Dissertation Institut für Pharmazeutische Technologie, Freie Universität Berlin .
   Google Scholar
• Muller , R. H. and Peters , K. 1998 . Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique . Int. J. Pharmaceut. , 160 : 229 – 237 .
   Google Scholar
• Krause , K. P. 2000 . Heavy metal contamination of nanosuspensions produced by high-pressure homogenisation . Int. J. Pharm. , 196 : 169 – 172 .
   Google Scholar
• Muller , R. H. , Krause , K. and Mader , K. Method for controlled production of ultrafine microparticles and nanoparticles . PCT Application PCT/EP2000/006535 . 2000 . Germany
   Google Scholar
• Bushrab , N. F. and Muller , R. H. 2003 . Nanocrystals of poorly soluble drugs for oral administration . New Drugs , 5 : 20 – 22 .
   Google Scholar
• Keck , C. M. , Kobierski , S. , Mauludin , R. and Muller , R. H. 2008 . Second generation of drug nanocrystals for delivery of poorly soluble drugs: smartCrystals technology . DOSIS , 24 : 125 – 130 .
   Google Scholar
• Hu , J. 2002 . Improvement of dissolution rates of poorly water soluble APIs using novel spray freezing into liquid technology . Pharm. Res. , 19 : 1278 – 1284 .
   Google Scholar
• Hanna , M. H. and York , P. Method and apparatus for the formulation of particles . US Patent 5,851,453 . 1998 . USA
   Google Scholar
• Hu , J. , Johnston , K. P. and Williams , R. O. 3rd . 2004 . Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs . Drug. Dev. Ind. Pharm. , 30 : 233 – 245 .
   Google Scholar
• Young , T. J. 1999 . Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent . J. Pharm. Sci. , 88 : 640 – 650 .
   Google Scholar
• Pace , G. W. Process to generate submicron particles of water insoluble compounds . US Patent 6, 103 . 2001 . USA
   Google Scholar
• Young , T. J. 2000 . Rapid expansion from supercritical to aqueous solution to produce submicron suspensions of water-insoluble drugs . Biotechnol. Prog. , 16 : 402 – 407 .
   Google Scholar
• Turk , M. and Lietzow , R. 2004 . Stabilized nanoparticles of phytosterol by rapid expansion from supercritical solution into aqueous solution . AAPS Pharm. Sci. Techol. , 5 ( 4 ) http://www.aapspharmscitech.org/view.asp?art=pt050456article 56
   Google Scholar
• Rogers , T. L. , Johnston , K. P. and Williams , R. O. 3rd . 2001 . Solution-based particle formation of pharmaceutical powders by supercritical or compressed fluid CO2 and cryogenic spray-freezing technologies . Drug Dev. Ind. Pharm. , 27 : 1003 – 1015 .
   Google Scholar
• Williams , R. O. Process for production of nanoparticles and microparticles by spray freezing into liquid . US Patent 20030041602 . 2003 . USA
   Google Scholar
• Chen , X. 2002 . Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution . Int. J. Pharm. , 242 : 3 – 14 .
   Google Scholar
• Elan , P. Drug technologies nanocrystals—technology overview . Presented at the Annual Meeting of Controlled Release Sociaty (CRS) . Long Beach , CA : CRS .
   Google Scholar
• Kesisoglou , F. , Panmai , S. and Wu , Y. 2007 . Nanosizing–oral formulation development and biopharmaceutical evaluation . Adv. Drug Deliv. Rev. , 59 : 631 – 644 .
   Google Scholar
• Jacobs , C. , Kayser , O. and Muller , R. H. 2001 . Production and characterization of mucoadhesive nanosuspensions for the formulation of bupravaquone . Int. J. Pharm. , 214 : 3 – 7 .
   Google Scholar
• Scholer , N. 2001 . Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis . Antimicrobial. Agents Chemother. , 45 : 1771 – 1779 .
   Google Scholar
• Wong , J. 2008 . Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects . Adv. Drug Deliv. Rev. , 60 : 939 – 954 .
   Google Scholar
• Gao , L. 2008 . Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions . Int. J. Pharm. , 355 : 321 – 327 .
   Google Scholar
• Yang , J. Z. 2008 . Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies . J. Pharm. Sci. , 97 : 4869 – 4878 .
   Google Scholar
• Hernandez-Trejo , N. 2005 . Characterization of nebulized buparvaquonenano suspensions—effect of nebulization technology . J. Drug Target , 13 : 499 – 507 .
   Google Scholar
• Piao , H. 2008 . A novel solid-in-oil nanosuspension for transdermal delivery of diclofenac sodium . Pharm. Res. , 25 : 896 – 901 .
   Google Scholar
• Pignatello , R. 2006 . Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene . AAPS Pharm. Sci. Techol. , 7 ( 1 ) http://www.aapspharmscitech.orgarticle 27
   Google Scholar
• Pignatello , R. , Bucolo , C. and Puglisi , G. 2002 . Ocular tolerability of EudragitRS100 and RL100 nanosuspensions as carriers for ophthalmic controlled drug delivery . J. Pharm. Sci. , 91 : 2636 – 2641 .
   Google Scholar
• Pignatello , R. 2002 . Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen . Eur. J. Pharm. Sci. , 16 : 53 – 61 .
   Google Scholar
• Pignatello , R. 2002 . Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application . Biomaterials , 23 : 3247 – 3255 .
   Google Scholar
• Kassem , M. A. 2007 . Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs . Int. J. Pharm. , 340 : 126 – 133 .
   Google Scholar